BRISTOL-MYERS SQUIBB CO (1BMY.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:1BMY • US1101221083

49.32 EUR
+1.62 (+3.39%)
Last: Feb 5, 2026, 07:00 PM
Fundamental Rating

6

Overall 1BMY gets a fundamental rating of 6 out of 10. We evaluated 1BMY against 55 industry peers in the Pharmaceuticals industry. 1BMY has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on 1BMY. 1BMY also has an excellent dividend rating. These ratings would make 1BMY suitable for value and dividend investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year 1BMY was profitable.
  • In the past year 1BMY had a positive cash flow from operations.
  • In multiple years 1BMY reported negative net income over the last 5 years.
  • 1BMY had a positive operating cash flow in each of the past 5 years.
1BMY.MI Yearly Net Income VS EBIT VS OCF VS FCF1BMY.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B 15B

1.2 Ratios

  • 1BMY's Return On Assets of 6.23% is in line compared to the rest of the industry. 1BMY outperforms 50.91% of its industry peers.
  • Looking at the Return On Equity, with a value of 32.55%, 1BMY is in the better half of the industry, outperforming 78.18% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 17.49%, 1BMY is doing good in the industry, outperforming 80.00% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1BMY is below the industry average of 14.23%.
  • The 3 year average ROIC (11.67%) for 1BMY is below the current ROIC(17.49%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.23%
ROE 32.55%
ROIC 17.49%
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)11.67%
ROIC(5y)9.83%
1BMY.MI Yearly ROA, ROE, ROIC1BMY.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • 1BMY has a Profit Margin (12.57%) which is in line with its industry peers.
  • Looking at the Operating Margin, with a value of 33.51%, 1BMY is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • 1BMY's Operating Margin has declined in the last couple of years.
  • 1BMY has a Gross Margin of 73.15%. This is comparable to the rest of the industry: 1BMY outperforms 56.36% of its industry peers.
  • 1BMY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 33.51%
PM (TTM) 12.57%
GM 73.15%
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
1BMY.MI Yearly Profit, Operating, Gross Margins1BMY.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • 1BMY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • The number of shares outstanding for 1BMY has been reduced compared to 1 year ago.
  • The number of shares outstanding for 1BMY has been reduced compared to 5 years ago.
  • The debt/assets ratio for 1BMY is higher compared to a year ago.
1BMY.MI Yearly Shares Outstanding1BMY.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
1BMY.MI Yearly Total Debt VS Total Assets1BMY.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

  • 1BMY has an Altman-Z score of 2.29. This is not the best score and indicates that 1BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of 1BMY (2.29) is comparable to the rest of the industry.
  • 1BMY has a debt to FCF ratio of 3.20. This is a good value and a sign of high solvency as 1BMY would need 3.20 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.20, 1BMY is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
  • A Debt/Equity ratio of 2.41 is on the high side and indicates that 1BMY has dependencies on debt financing.
  • 1BMY has a Debt to Equity ratio of 2.41. This is amonst the worse of the industry: 1BMY underperforms 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF 3.2
Altman-Z 2.29
ROIC/WACC2.02
WACC8.68%
1BMY.MI Yearly LT Debt VS Equity VS FCF1BMY.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 1.27 indicates that 1BMY should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.27, 1BMY is doing worse than 61.82% of the companies in the same industry.
  • A Quick Ratio of 1.17 indicates that 1BMY should not have too much problems paying its short term obligations.
  • 1BMY has a better Quick ratio (1.17) than 65.45% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.17
1BMY.MI Yearly Current Assets VS Current Liabilites1BMY.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 460.68% over the past year.
  • The earnings per share for 1BMY have been decreasing by -24.57% on average. This is quite bad
  • The Revenue has been growing slightly by 1.26% in the past year.
  • 1BMY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.06% yearly.
EPS 1Y (TTM)460.68%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-9.44%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%2.77%

3.2 Future

  • Based on estimates for the next years, 1BMY will show a very strong growth in Earnings Per Share. The EPS will grow by 35.29% on average per year.
  • 1BMY is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.06% yearly.
EPS Next Y471.99%
EPS Next 2Y130.77%
EPS Next 3Y73.18%
EPS Next 5Y35.29%
Revenue Next Year0.22%
Revenue Next 2Y-4.02%
Revenue Next 3Y-3.34%
Revenue Next 5Y-5.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1BMY.MI Yearly Revenue VS Estimates1BMY.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
1BMY.MI Yearly EPS VS Estimates1BMY.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

9

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 8.87, which indicates a very decent valuation of 1BMY.
  • 1BMY's Price/Earnings ratio is rather cheap when compared to the industry. 1BMY is cheaper than 90.91% of the companies in the same industry.
  • 1BMY is valuated cheaply when we compare the Price/Earnings ratio to 27.92, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 9.58, the valuation of 1BMY can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, 1BMY is valued cheaper than 85.45% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of 1BMY to the average of the S&P500 Index (27.78), we can say 1BMY is valued rather cheaply.
Industry RankSector Rank
PE 8.87
Fwd PE 9.58
1BMY.MI Price Earnings VS Forward Price Earnings1BMY.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 1BMY's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. 1BMY is cheaper than 92.73% of the companies in the same industry.
  • 1BMY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1BMY is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.74
EV/EBITDA 7.13
1BMY.MI Per share data1BMY.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • 1BMY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1BMY's earnings are expected to grow with 73.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y130.77%
EPS Next 3Y73.18%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. Dividend

5.1 Amount

  • 1BMY has a Yearly Dividend Yield of 4.64%, which is a nice return.
  • 1BMY's Dividend Yield is rather good when compared to the industry average which is at 1.95. 1BMY pays more dividend than 85.45% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, 1BMY pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.64%

5.2 History

  • On average, the dividend of 1BMY grows each year by 11.67%, which is quite nice.
Dividend Growth(5Y)11.67%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 82.81% of the earnings are spent on dividend by 1BMY. This is not a sustainable payout ratio.
  • 1BMY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP82.81%
EPS Next 2Y130.77%
EPS Next 3Y73.18%
1BMY.MI Yearly Income VS Free CF VS Dividend1BMY.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B 15B
1BMY.MI Dividend Payout.1BMY.MI Dividend Payout, showing the Payout Ratio.1BMY.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

BRISTOL-MYERS SQUIBB CO

BIT:1BMY (2/5/2026, 7:00:00 PM)

49.32

+1.62 (+3.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30
Earnings (Next)02-05
Inst Owners81.87%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap100.40B
Revenue(TTM)48.03B
Net Income(TTM)6.04B
Analysts70
Price Target48.98 (-0.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.64%
Yearly Dividend2.03
Dividend Growth(5Y)11.67%
DP82.81%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.98%
Min EPS beat(2)6.92%
Max EPS beat(2)35.04%
EPS beat(4)4
Avg EPS beat(4)18.72%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.52%
EPS beat(12)11
Avg EPS beat(12)11.66%
EPS beat(16)15
Avg EPS beat(16)10.13%
Revenue beat(2)2
Avg Revenue beat(2)4.61%
Min Revenue beat(2)2.43%
Max Revenue beat(2)6.79%
Revenue beat(4)4
Avg Revenue beat(4)4.63%
Min Revenue beat(4)2.43%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.95%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)11
Avg Revenue beat(16)1.64%
PT rev (1m)8.16%
PT rev (3m)10.36%
EPS NQ rev (1m)-33.1%
EPS NQ rev (3m)-29.54%
EPS NY rev (1m)-1.3%
EPS NY rev (3m)-0.98%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)2.05%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)1.35%
Valuation
Industry RankSector Rank
PE 8.87
Fwd PE 9.58
P/S 2.47
P/FCF 7.74
P/OCF 7.13
P/B 6.39
P/tB N/A
EV/EBITDA 7.13
EPS(TTM)5.56
EY11.27%
EPS(NY)5.15
Fwd EY10.43%
FCF(TTM)6.37
FCFY12.92%
OCF(TTM)6.92
OCFY14.03%
SpS20
BVpS7.72
TBVpS-9.85
PEG (NY)0.02
PEG (5Y)N/A
Graham Number31.09
Profitability
Industry RankSector Rank
ROA 6.23%
ROE 32.55%
ROCE 23.41%
ROIC 17.49%
ROICexc 22.99%
ROICexgc 117.18%
OM 33.51%
PM (TTM) 12.57%
GM 73.15%
FCFM 31.86%
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)11.67%
ROIC(5y)9.83%
ROICexc(3y)13.73%
ROICexc(5y)11.71%
ROICexgc(3y)74.95%
ROICexgc(5y)76.74%
ROCE(3y)15.62%
ROCE(5y)13.15%
ROICexgc growth 3Y-16.88%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y7.41%
ROICexc growth 5Y19.82%
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 2.41
Debt/FCF 3.2
Debt/EBITDA 2.13
Cap/Depr 26.84%
Cap/Sales 2.75%
Interest Coverage 7.66
Cash Conversion 79.11%
Profit Quality 253.39%
Current Ratio 1.27
Quick Ratio 1.17
Altman-Z 2.29
F-Score6
WACC8.68%
ROIC/WACC2.02
Cap/Depr(3y)12.09%
Cap/Depr(5y)10.53%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)460.68%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-9.44%
EPS Next Y471.99%
EPS Next 2Y130.77%
EPS Next 3Y73.18%
EPS Next 5Y35.29%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%2.77%
Revenue Next Year0.22%
Revenue Next 2Y-4.02%
Revenue Next 3Y-3.34%
Revenue Next 5Y-5.06%
EBIT growth 1Y44.7%
EBIT growth 3Y0.79%
EBIT growth 5Y8.21%
EBIT Next Year220.11%
EBIT Next 3Y49.61%
EBIT Next 5Y23.19%
FCF growth 1Y30.91%
FCF growth 3Y-2.91%
FCF growth 5Y14.03%
OCF growth 1Y28.71%
OCF growth 3Y-2.14%
OCF growth 5Y13.49%

BRISTOL-MYERS SQUIBB CO / 1BMY.MI FAQ

Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?

ChartMill assigns a fundamental rating of 6 / 10 to 1BMY.MI.


Can you provide the valuation status for BRISTOL-MYERS SQUIBB CO?

ChartMill assigns a valuation rating of 9 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.


Can you provide the profitability details for BRISTOL-MYERS SQUIBB CO?

BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 5 / 10.


Can you provide the financial health for 1BMY stock?

The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 5 / 10.


Is the dividend of BRISTOL-MYERS SQUIBB CO sustainable?

The dividend rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 8 / 10 and the dividend payout ratio is 82.81%.